Motif Bio up 15% premarket ahead of Inclaprim presentations

|About: Motif Bio plc (MTFB)|By:, SA News Editor

Nano cap Motif Bio plc (NASDAQ:MTFB) perks up 15% premarket on average volume in apparent response to upcoming abstracts on iclaprim to be presented at ECCMID in Amsterdam starting next Saturday, April 13.

Subscribe for full text news in your inbox